Surgical curability of medullary thyroid cancer in multiple endocrine neoplasia 2b: A changing perspective

Annals of Surgery

Volumn 259, Issue 4, 2014, Pages 800-806

  Brauckhoff, Michael ^a,b,c   Machens, Andreas ^a   Lorenz, Kerstin ^a   Bjøro, Trine ^d,e   Varhaug, Jan Erik ^b,c   Dralle, Henning ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cancer specific survival; intestinal ganglioneuromatosis; medullary thyroid carcinoma; MEN 2B; tearless crying

Indexed keywords

CALCITONIN;

ADOLESCENT; ADULT; CALCITONIN BLOOD LEVEL; CANCER DIAGNOSIS; CANCER SURGERY; CHILD; CLINICAL ARTICLE; DISTANT METASTASIS; EARLY DIAGNOSIS; EYE DISEASE; FEMALE; GANGLIONEUROMA; GENE MUTATION; HETEROZYGOTE; HUMAN; INFANT; INTESTINE TUMOR; LYMPH NODE METASTASIS; MALE; MOUTH DISEASE; MUSCULOSKELETAL DISEASE; NEUROFIBROMATOSIS; ONCOGENE RET; PHEOCHROMOCYTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; THYROID MEDULLARY CARCINOMA; TUMOR VOLUME; YOUNG ADULT;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GENETIC MARKERS; HUMANS; INFANT; KAPLAN-MEIER ESTIMATE; MALE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B; MUTATION; NECK DISSECTION; PHEOCHROMOCYTOMA; PROTO-ONCOGENE PROTEINS C-RET; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84895918481     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3182a6f43a     Document Type: Review

References (40)

1. Machens A, Lorenz K, Sekulla C, et al. Molecular epidemiology of multiple endocrine neoplasia 2: Implications for RET screening in the new millennium. Eur J Endocrinol. 2013;18:307-314.
2. Eng C, Clayton D, Schuffenecker I, et al. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type. International RET mutation consortium analysis. JAMA. 1996;276:1575-1579.
3. Kloos RT, Eng C, Evans DB, et al. Medullary thyroid cancer: Management guidelines of the American Thyroid Association. Thyroid. 2009;19:565-612.
4. Romei C, Mariotti S, Fugazzola L, et al. Multiple endocrine neoplasia type 2 syndromes (MEN 2): Results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. Eur J Endocrinol. 2010;163:301-308.
5. Gimm O, Marsh DJ, Andrew SD, et al. Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation. J Clin Endocrinol Metab. 1997;82:3902-3904.
6. Smith DP, Houghton C, Ponder BA. Germline mutation of RET codon 883 in two cases of De novo MEN 2B. Oncogene. 1997;15:1213-1217.
7. Miyauchi A, Futami H, Hai N, et al. Two germline missense mutations at codons 804 and 806 of the RET proto-oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutation. Jpn J Cancer Res. 1999;90:1-5.
8. Brauckhoff M, Machens A, Hess S, et al. Premonitory symptoms preceding metastatic medullary thyroid cancer in MEN 2B: An exploratory analysis. Surgery. 2008;144:1044-1050.
9. Zenaty D, Aigrain Y, Peuchmaur M, et al. Medullary thyroid carcinoma identified within the first year of life in children with hereditary multiple endocrine neoplasia type 2A (codon 634) and 2B. Eur J Endocrinol. 2009;160:807-813.
10. Unruh A, Fitze G, Janig U, et al. Medullary thyroid carcinoma in a 2-monthold male with multiple endocrine neoplasia 2B and symptoms of pseudo-Hirschsprung disease: A case report. J Pediatr Surg. 2007;42:1623-1626.
11. Waguespack SG, Rich TA. Multiple endocrine neoplasia syndrome type 2B in early childhood: Long-term benefit of prophylactic thyroidectomy. Cancer. 2010;116:2284.
12. Cohen MS, Phay JE, Albinson C, et al. Gastrointestinal manifestations of multiple endocrine neoplasia type. Ann Surg. 2002;235:648-654.
13. Evans CA, Nesbitt IM, Walker J, et al. MEN 2B syndrome should be part of the working diagnosis of constipation of the newborn. Histopathology. 2008;52:646-648.
14. Brauckhoff M, Gimm O, Weiss CL, et al. Multiple endocrine neoplasia 2B syndrome due to codon 918 mutation: Clinical manifestation and course in early and late onset disease. World J Surg. 2004;28:1305-1311.
15. Thorat C, Xu K, Freeman SN, et al. What the Orphan Drug Act has done lately for children with rare diseases: A 10-year analysis. Pediatrics. 2012;129:516-521.
16. Engiz O, Ocal G, Siklar Z, et al. Early prophylactic thyroidectomy for RET mutation-positive MEN 2B. Pediatr Int. 2009;51:590-593.
17. Samaan NA, Draznin MB, Halpin RE, et al.Multiple endocrine syndrome type IIb in early childhood. Cancer. 1991;68:1832-1834.
18. Nguyen L, Niccoli-Sire P, Caron P, et al. Pheochromocytoma in multiple endocrine neoplasia type 2: A prospective study. Eur J Endocrinol. 2001;144: 37-44.
19. Carney JA,GoVL, SizemoreGW, et al.Alimentary-tract ganglioneuromatosis. A major component of the syndrome of multiple endocrine neoplasia, type 2b. N Engl J Med. 1976;295:1287-1291.
20. Smith VV, Eng C, Milla PJ. Intestinal ganglioneuromatosis and multiple endocrine neoplasia type 2B: Implications for treatment. Gut. 1999;45:143-146.
21. Swaminathan M, Kapur RP. Counting myenteric ganglion cells in histologic sections: An empirical approach. Hum Pathol. 2010;41:1097-1108.
22. Ledwidge SF, Moorghen M, Longman RJ, et al. Adult transmural intestinal ganglioneuromatosis is not always associated with multiple endocrine neoplasia or neurofibromatosis: A case report. J Clin Pathol. 2007;60: 222-223
23. Feichter S, Meier-RugeWA, et al. The histopathology of gastrointestinal motility disorders in children. Semin Pediatr Surg. 2009;18:206-211
24. Wagenmann A. Multiple Neurome des Auges und Der Zunge. Ber Dtsch Ophthal Ges. 1922;43:282-285.
25. Froboese C. Das aus markhaltigen Nervenfasern bestehende, ganglienzellose, echte Neurom in Rankenform. Zugleich ein Beitrag zu Den nervosen Geschwulsten Der Zunge und des Augenlides. Virchows Arch Pathol Anat. 1923;240:312-327.
26. Gorlin RJ, Sedano HO, Vickers RA, et al. Multiple mucosal neuromas, pheochromocytoma and medullary carcinoma of the thyroid - a syndrome. Cancer. 1968;22:293-299.
27. Schimke RN, HartmannWH, Prout TE, et al. Syndrome of bilateral pheochromocytoma, medullary thyroid carcinoma and multiple neuromas. A possible regulatory defect in the differentiation of chromatin tissues. N Engl J Med. 1968;279:1-8.
28. Williams ED, Pollock DJ. Multiple mucosal neuromata with endocrine tumours: A syndrome allied to von Recklinghausen's disease. J Pathol Bacteriol. 1966;91:71-80.
29. Chong GC, Beahrs OH, Sizemore GW, et al. Medullary carcinoma of the thyroid gland. Cancer. 1975;35:695-704.
30. Carney JA, Sizemore GW, Hayles AB. Multiple endocrine neoplasia, type 2b. Pathobiol Annu. 1978;8:105-153
31. Vasen HFA, Van Der Feltz M, Raue F, et al. The natural course of multiple endocrine neoplasia type 2B. Arch Intern Med. 1992;152:1250-1252.
32. O'Riodrain DS, O'Brien T, Crotty TB, et al. Multiple endocrine neoplasia type 2B: More than an endocrine disorder. Surgery. 1995;118:936-942.
33. Skinner MA, DeBenedetti MK, Moley JF, et al. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B. J Pediatr Surg. 1996;31:177-181.
34. Leboulleux S, Travagli JP, Caillou B, et al. Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome. Cancer. 2002;94:44-50.
35. Wray CJ, Rich TA, Waguespack SG, et al. Failure to recognize multiple endocrine neoplasia 2B: More common than we think Ann Surg Oncol. 2008;15:293-301.
36. Borrello MG, Smith DP, Pasini B, et al. RET activation by germline MEN2A and MEN2B mutations. Oncogene. 1995;11:2419-2427.
37. Iwashita T, Murakami H, Kurokawa K, et al. A two-hit model for development of multiple endocrine neoplasia type 2B by RET mutations. Biochem Biophys Res Commun. 2000;268:804-808.
38. Cranston AN, Carniti C, Oakhill K, et al. RET is constitutively activated by novel tandem mutations that alter the active site resulting in multiple endocrine neoplasia type 2B. Cancer Res. 2006;66:10179-10187.
39. Menko FH, Van Der Luijt RB, De Valk IA, et al. Atypical MEN type 2b associated with two germline RET mutations on the same allele not involving codon 918. J Clin Endocrinol Metab. 2002;87:393-397.
40. Jasim S, Ying AK, Waguespack SG, et al. Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation. Thyroid. 2011;21:189-192.